Cardiovascular and heart health is a fast developing area of interest within the fields of lignan research. The principle for using lignans for cardiovascular and heart health promotion extends beyond the traditional “cholesterol approach” and encompasses a variety of biological components such as “anti-inflammation” “antioxidancy” and the endocrine system.  

In addition to current clinical investigations, a strong epidemiological link between cardiovascular mortality rates and plasma enterolactone levels has been established in a range of studies.